Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing

CONCLUSIONS: Our studies suggested that mutation targeting may hold promise as a versatile and effective approach to treating liver cancers.PMID:38497929 | PMC:PMC10948134 | DOI:10.1097/HC9.0000000000000412

Source: Herpes - March 18, 2024 Category: Infectious Diseases Authors: Muhamuda Kader Wei Sun Bao-Guo Ren Yan-Ping Yu Junyan Tao Lesley M Foley Silvia Liu Satdarshan P Monga Jian-Hua Luo Source Type: research